Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite an increase
Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results
Categories
Health Care
Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a share price
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharmaceutical company focused on clinical programs in oncology, fibrosis, infectious disease, and inflammation. Its business
Infographic: How Medtronic (MDT) performed in Q4 2023
Medtronic plc (NYSE: MDT) reported fourth quarter 2023 earnings results today. Revenue was $8.5 billion, up 5.6% year-over-year, both on a reported
Ocean Biomedical (OCEA) set to join the Russell 2000 Index
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index, effective after
Strides Pharma Science Limited (STAR) Q4 2023 Earnings Con Call Transcript
Strides Pharma Science Limited ( ?????? : STAR) Q4 2023 Earnings Con Call dated May. 25, 2023 Corporate participants: Arun Kumar --
Agilent Technologies (A) Q2 2023 earnings, revenue increase
Agilent Technologies (NYSE: A) has announced second-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment
Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad patent for
Ocean Biomedical announces private placement of $25 mln convertible notes
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a securities purchase
Cara Therapeutics Inc (CARA) Q1 2023 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ: CARA) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Matthew Murphy -- Manager of Investor Relations Christopher Posner -- Chief
TRxADE HEALTH Inc (MEDS) Q1 2023 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel -- Interim Chief Financial Officer Suren Ajjarapu -- Chairman and
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter of fiscal
Bio Path Holdings Inc (BPTH) Q1 2023 Earnings Call Transcript
Bio Path Holdings Inc (NASDAQ:BPTH) Q1 2023 Earnings Call dated May. 12, 2023. Corporate Participants: Will O'Connor -- Managing Director Peter H. Nielsen -- Chairman, President,
Catalyst Pharmaceuticals Inc (CPRX) Q1 2023 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q1 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
Veru Inc (VERU) Q2 2023 Earnings Call Transcript
Veru Inc (NASDAQ:VERU) Q2 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Samuel Fisch -- Executive Director of Investor Relations and Corporate Communications
BioLife Solutions Inc (BLFS) Q1 2023 Earnings Call Transcript
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman & Chief
Jazz Pharmaceuticals PLC (JAZZ) Q1 2023 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Andrea Flynn -- Vice President and Head, Investor Relations Bruce
Perrigo Co PLC (PRGO) Q1 2023 Earnings Call Transcript
Perrigo Co PLC (NYSE: PRGO) Q1 2023 Earnings Call dated May. 09, 2023. Corporate Participants: Bradley Joseph -- Vice President of Investor
A snapshot of McKesson Corporation’s Q4 2023 earnings
Healthcare service provider McKesson Corporation (NYSE: MCK) announced financial results for the fourth quarter of 2023, reporting a 4% increase in revenues.
McKesson Corporation (MCK) Q4 2023 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Nicole Kramer -- Manager of Investor Relations Brian Tyler -- Chief Executive Officer
ANI Pharmaceuticals Inc (ANIP) Q1 2023 Earnings Call Transcript
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- Chief Executive Officer Stephen